Exact Science’s Michelle Beidelschies, PhD, reveals how a multi-biomarker class multi-cancer early detection test (MCED) blood test can help health systems expand detection across more cancers earlier ...

A second blood test shows promise for the detection of colon cancer, according to a new study. The first, called Shield, was approved by the Food and Drug Administration in July for people 45 and ...

More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...

WHEN James Rogers first spotted blood in his poo his doctors insisted it wouldn’t be cancer. They even ran blood tests on the ...

An investigational blood test for early detection of colorectal cancer (CRC) in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC study, the largest study ...

A new FDA-approved blood test designed to detect colon cancer earlier is now available in North Texas. An estimated 154,270 people in the U.S. will be diagnosed with colorectal cancer this year. It's ...

When you breathe out, you’re not just releasing carbon dioxide. Your breath carries a complex mix of volatile organic compounds, or VOCs—tiny molecules that come from normal body processes. These ...

Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...

A new blood test can detect lung cancer in real time, enabling earlier diagnosis, quicker treatment, reduced delays, and improved survival outcomes for patients.

More women with ovarian cancer could be diagnosed earlier under proposed new NICE guidance that replaces a one-size-fits-all blood test threshold with personalised, age-based criteria.

A major update to federal women’s health preventive guidance will make it easier for women to get screened for cervical ...